Stoke Therapeutics, Inc.

Invesco Ltd. STOK
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/12/2026
Shares
150,045
Value ($000)
4,885
Weight
0.0%
2020 Q4 - 2026 Q1 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).